Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial.

Jimenez-Quevedo P, Brugaletta S, Cequier A, Iñiguez A, Serra A, Mainar V, Campo G, Tespili M, Nombela-Franco L, Del Trigo M, Gonzalo N, Escaned J, Salinas P, Nuñez-Gil I, Fernandez-Perez C, Fernández-Ortiz A, Macaya C, Serruys PW, Sabate Tenas M.

Catheter Cardiovasc Interv. 2019 Mar 20. doi: 10.1002/ccd.28194. [Epub ahead of print]

PMID:
30895706
2.

Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial.

Rothenbühler M, Valgimigli M, Odutayo A, Frigoli E, Leonardi S, Vranckx P, Turturo M, Moretti L, Amico F, Uguccioni L, Contarini M, Gómez-Hospital JA, Mainar V, Creaco M, Petronio AS, Cremonesi A, Tamburino C, Fresco C, Bonmassari R, Díaz Fernández JF, Romagnoli E, Beyersmann J, Heg D, Jüni P.

Eur Heart J. 2019 Apr 14;40(15):1226-1232. doi: 10.1093/eurheartj/ehy860.

PMID:
30689825
3.

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial.

Schur N, Brugaletta S, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Ademi Z, Schwenkglenks M, Sabaté M.

PLoS One. 2018 Aug 16;13(8):e0201985. doi: 10.1371/journal.pone.0201985. eCollection 2018.

4.

Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry.

Amat-Santos IJ, Martin-Yuste V, Fernández-Díaz JA, Martin-Moreiras J, Caballero-Borrego J, Salinas P, Ojeda S, Rivero F, Núñez Villota J, Mohandes M, Dubois D, Bosa Ojeda F, Rumiz E, de la Torre Hernández JM, Jiménez-Mazuecos J, Lacunza J, Tejedor P, Gómez I, Goncalves-Ramirez LR, Rojas P, Sabaté M, Goicolea J, Diego Nieto A, Jiménez-Fernández M, Escaned J, Gonzalo N, Pardo L, Cuesta J, Miñana G, Sanchis J, Rojas S, Millán R, Vaquerizo B, Rodríguez S, Lee DH, Morales FJ, Gutiérrez A, López M, Maristany J, Rondán J, Galeote G, Kabbanni Z, Rodríguez S, Teruel L, Sadaba M, Jurado A, Mainar V, Sánchez-Rubio J, Vinhas H, Fernandes R.

Rev Esp Cardiol (Engl Ed). 2019 May;72(5):373-382. doi: 10.1016/j.rec.2018.05.020. Epub 2018 Jun 25. English, Spanish.

PMID:
29954721
5.

3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.

Alfonso F, Pérez-Vizcayno MJ, Cuesta J, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Cequier A, Velázquez M, Moreno R, Mainar V, Domínguez A, Moris C, Molina E, Rivero F, Jiménez-Quevedo P, Gonzalo N, Fernández-Pérez C; RIBS IV Study Investigators (Under the Auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology).

JACC Cardiovasc Interv. 2018 May 28;11(10):981-991. doi: 10.1016/j.jcin.2018.02.037.

PMID:
29798776
6.

Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial).

Spitaleri G, Brugaletta S, Scalone G, Moscarella E, Ortega-Paz L, Pernigotti A, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M.

Am J Cardiol. 2018 May 1;121(9):1039-1045. doi: 10.1016/j.amjcard.2018.01.015. Epub 2018 Feb 7.

PMID:
29544865
7.

Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial.

Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M.

EuroIntervention. 2018 Mar 20;13(16):1939-1945. doi: 10.4244/EIJ-D-17-00608.

8.

Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation.

Moscarella E, Spitaleri G, Brugaletta S, Sentí Farrarons S, Pernigotti A, Ortega-Paz L, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M.

Am J Cardiol. 2017 Nov 1;120(9):1460-1466. doi: 10.1016/j.amjcard.2017.07.040. Epub 2017 Jul 31.

PMID:
28864322
9.

Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial.

Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys PW, Sabaté M.

EuroIntervention. 2017 Aug 4;13(5):e557-e563. doi: 10.4244/EIJ-D-16-00512.

10.

Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.

Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Melgares R, Mainar V, Moreno R, Domínguez A, Sanchís J, Bethencourt A, Moreu J, Cequier A, Martí V, Otaegui I, Bastante T, Gonzalo N, Jiménez-Quevedo P, Cárdenas A, Fernández C; under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology.

Circ Cardiovasc Interv. 2016 Jul;9(7). pii: e003479. doi: 10.1161/CIRCINTERVENTIONS.115.003479.

PMID:
27412868
11.

Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry).

Hernández-Enriquez M, Andrea R, Brugaletta S, Jiménez-Quevedo P, Hernández-García JM, Trillo R, Larman M, Fernández-Avilés F, Vázquez-González N, Iñiguez A, Zueco J, Ruiz-Salmerón R, Del Valle R, Molina E, García Del Blanco B, Berenguer A, Valdés M, Moreno R, Urbano-Carrillo C, Hernández-Antolín R, Gimeno F, Cequier Á, Cruz I, López-Mínguez JR, Aramendi JI, Sánchez Á, Goicolea J, Albarrán A, Díaz JF, Navarro F, Moreu J, Morist A, Fernández-Nofrerías E, Fernández-Vázquez F, Ten F, Mainar V, Mari B, Saenz A, Alfonso F, Diarte JA, Sancho M, Lezáun R, Arzamendi D, Sabaté M.

Am J Cardiol. 2016 Aug 15;118(4):578-84. doi: 10.1016/j.amjcard.2016.05.054. Epub 2016 May 29.

PMID:
27378142
12.

A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.

Jiménez VA, Iñiguez A, Baz JA, Valdés M, Ortiz A, Vuilliomenet A, Mainar V, Dudek D, Banai S, Tüller D, Bonnet JL, De Miguel A, Bastos G, Wijns W, Saito S.

Cardiovasc Revasc Med. 2016 Sep;17(6):355-61. doi: 10.1016/j.carrev.2016.04.001. Epub 2016 Apr 19.

13.

Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary intervention.

Ruiz-Nodar JM, Gómez-Sansano JM, Galcerá E, Mainar V, Valencia J, Pineda J, Bordes P, Ramos D, Sogorb F, Lip GY.

Int J Cardiol. 2016 Jun 1;212:371-6. doi: 10.1016/j.ijcard.2016.03.077. Epub 2016 Mar 23.

PMID:
27064525
14.

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial.

Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, van Es GA, Backx B, Valgimigli M, Serruys PW.

Lancet. 2016 Jan 23;387(10016):357-366. doi: 10.1016/S0140-6736(15)00548-6. Epub 2015 Oct 29.

15.

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.

Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García del Blanco B, García-Touchard A, López-Minguéz JR, Benedicto A, Masotti M, Zueco J, Iñiguez A, Velázquez M, Moreno R, Mainar V, Domínguez A, Pomar F, Melgares R, Rivero F, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C; RIBS IV Study Investigators (under auspices of Interventional Cardiology Working Group of Spanish Society of Cardiology).

J Am Coll Cardiol. 2015 Jul 7;66(1):23-33. doi: 10.1016/j.jacc.2015.04.063.

16.

Comparison between diabetic and non-diabetic patients after successful percutaneous coronary intervention for chronic total occlusions in the drug-eluting stent era.

Ruiz-Garcia J, Teles R, Rumoroso JR, Cyrne Carvalho H, Goicolea FJ, Moreu J, Mauri J, Mainar V, García E, Moreno R; CIBELES investigators.

Rev Port Cardiol. 2015 Apr;34(4):263-70. doi: 10.1016/j.repc.2014.10.009. Epub 2015 Apr 1.

17.

Drug-eluting stent thrombosis in the treatment of chronic total coronary occlusions: incidence, presentation and related factors. Data from the CIBELES trial.

Arroyo-Úcar E, Moreno R, García E, Teles R, Rumoroso JR, Carvalho HC, Goicolea FJ, Moreu J, Mauri J, Sabaté M, Mainar V, Patricio L, Valdés M, Fernández-Vázquez F, Sánchez-Recalde A, Galeote G, Jimenez-Valero S, Almeida M, López de Sa E, Calvo L, Plaza I, Lopez-Sendón JL, Martín JL; CIBELES investigators.

Rev Port Cardiol. 2015 Mar;34(3):193-9. doi: 10.1016/j.repc.2014.08.026. Epub 2015 Feb 14.

18.

Everolimus-eluting stent versus bare-metal stent in elderly (≥75 years) versus non-elderly (<75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the examination trial.

Ielasi A, Brugaletta S, Silvestro A, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, den Heijer P, Bethencourt A, Vazquez N, Serruys P, Sabate M, Tespili M.

Int J Cardiol. 2015 Jan 20;179:73-8. doi: 10.1016/j.ijcard.2014.10.038. Epub 2014 Oct 22.

PMID:
25464418
19.

Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials.

Taniwaki M, Stefanini GG, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostoijic M, Hernandez-Antolin R, Baumbach A, Blöchlinger S, Jüni P, Mainar V, Sabate M, Windecker S.

EuroIntervention. 2015 Aug;11(4):391-8. doi: 10.4244/EIJY14M07_12.

20.

Optimization in stent implantation by manual thrombus aspiration in ST-segment-elevation myocardial infarction: findings from the EXAMINATION trial.

Fernández-Rodríguez D, Regueiro A, Brugaletta S, Martín-Yuste V, Masotti M, Cequier A, Iñíguez A, Serra A, Hernández-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Serruys PW, Sabaté M; EXAMINATION investigators.

Circ Cardiovasc Interv. 2014 Jun;7(3):294-300. doi: 10.1161/CIRCINTERVENTIONS.113.000964. Epub 2014 May 27.

PMID:
24867891

Supplemental Content

Loading ...
Support Center